SCHEMBL9515835

SCHEMBL9515835

O=CC(c1ccc(F)cc1F)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
HDAC6 Q9UBN7 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
P4HTM Q9NXG6 2/20 0.36
CASP3 P42574 7/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
KLKB1 P03952 1/20 0.33
GABRA5 P31644 1/20 0.33
SCN9A Q15858 1/20 0.33
CASP1 P29466 1/20 0.33
CASP2 P42575 1/20 0.33
CASP4 P49662 1/20 0.33
CASP5 P51878 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516321 0.88 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9515669 0.87 LMNA (0.38) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9517183 0.86 LMNA (0.38) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9516939 0.86 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9518019 0.85 MEN1 (0.39) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515522 0.84 LMNA (0.37) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9517025 0.84 CASP3 (0.39) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515843 0.80 LMNA (0.40) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9515748 0.79 P4HTM (0.39) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9517189 0.79 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed